Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Bio Clinical Collection of Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- N/A
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
- Status
- COMPLETED
- Phase
- N/A
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
- Status
- RECRUITING
- Phase
- N/A
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Status
- RECRUITING
- Phase
- PHASE2
Pre-operative Immunotherapy in Stage II-III Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic
- Status
- UNKNOWN
- Phase
- N/A
Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
- Status
- UNKNOWN
- Phase
- N/A
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE3
TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2